3 results found
As software developers, we're accustomed to A/B testing product features, meticulously measuring lift, and shipping based on a statistically significant p-value. This tried-and-true method works for many scenarios.
Every product experimentation team eventually confronts a common challenge when launching new features, especially those leveraging Large Language Models (LLMs): the 'Opt-In Trap'. Imagine shipping a new AI assistant
Billionaire-backed startup R3 Bio is developing genetically-engineered, nonsentient "organ sacks" to replace animal testing. This initiative aligns with the Trump administration's efforts to phase out animal experimentation, offering a potentially humane and effective alternative for scientific research. The company aims to eventually create human versions for personalized medical testing.
